855 results on '"Coy, David H."'
Search Results
2. Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice
3. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes
4. Somatostatin receptor antagonists based on a mixed neuromedin B antagonist/somatostatin agonist
5. Pharmacology of Growth Hormone-Releasing Hormone and Its Peptide Analogs
6. Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion
7. Pharmacology of GRF and Somatostatin: Positive and Negative Control of GH Release
8. Peptide-Neuromedin B (NMB) Receptor Interactions: Comparison with Gastrin-Releasing Peptide (GRP) Receptor Interactions
9. Structural Analysis of Ligand Binding Characteristics for the Bombesin/Gastrin-Releasing Peptide Receptor
10. Structure-Dependent Inhibitory Effect of Galanin on Insulin, Gastric Acid and Pancreatic Amylase Secretion in Rat
11. Insights into bombesin receptors and ligands: Highlighting recent advances
12. A structure–function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists
13. Isolation and Structure of Pro-Methionine-Enkephalin: Potential Enkephalin Precursor from Porcine Hypothalamus
14. Isolation, Structure, Biological Characterization, and Synthesis of β -[Tyr 9 ]Melanotropin-(9-18) Decapeptide from Pig Hypothalami
15. Synthesis and Biological Actions of Prosomatostatin
16. Inhibition of Growth of a Prolactin-Secreting Pituitary Tumor in Rats by Analogs of Luteinizing Hormone-Releasing Hormone and Somatostatin
17. Gastrointestinal Secretory, Motor, Circulatory, and Metabolic Effects of Prosomatostatin
18. Stimulation of Cyclic AMP Accumulation and Corticotropin Release by Synthetic Ovine Corticotropin-Releasing Factor in Rat Anterior Pituitary Cells: Site of Glucocorticoid Action
19. Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II
20. Synthesis of camptothecin–amino acid carbamate linkers
21. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, αVβ3/αVβ5 and MMP-2/-9
22. Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
23. Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
24. A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit
25. Responses to human CGRP, ADM, and PAMP in human thymic arteries
26. Development of somatostatin agonists with high affinity and specificity for the human and rat type 5 receptor subtype
27. The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members
28. Exploration of the DTrp-NMeLys Motif in the Search for Potent Somatostatin Antagonists
29. Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
30. Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase
31. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs
32. Somatostatin Analogues and Multiple Receptors: Possible Physiological Roles
33. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): Affinities, potencies and selectivity in multiple native and BnR transfected cells
34. Characterization of putative GRP- and NMB-receptor antagonistʼs interaction with human receptors
35. Vasoactive intestinal peptide–camptothecin conjugates inhibit the proliferation of breast cancer cells
36. Modulation of secretin release by neuropeptides in secretin-producing cells
37. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo
38. Bombesin-like peptides stimulate somatostatin release from rat fundic D cells in primary culture
39. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep
40. Proadrenomedullin NH2-terminal 20 peptide has direct vasodilator activity in the cat
41. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat
42. Brain β-endorphin-like immunoreactivity in adult rats given β-endorphin neonatally
43. Neonatal administration of β-endorphin produces “chronic” insensitivity to thermal stimuli
44. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells
45. Somatostatin-receptor 2 (sst2)-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach
46. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP)
47. Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells
48. Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells
49. Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP
50. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.